Virtual 2021 BioHealth Capital Region Forum

Top 3 by 2023

September 13-14, 2021 Two Half-Days

About

This event is free for executive-level biotech leaders and is organized by the following event partners – Association of University Research Parks, AstraZeneca, BioHealth Innovation, BRAINBox Solutions, Inc, Children’s National Hospital, Emergent BioSolutions, George Mason University, Johnson & Johnson Innovation – JLABS @ Washington, DC, Maryland Department of Commerce, and Virginia Bio.

NOTE: Your registration for this event also enables you to view the 2021 BioHealth Capital Region Crab Trap Competition

taking place on September 29, 2021

2021 Agenda

Agenda Subject To Updates

8:30 – Welcoming Remarks

9:05 – GEN Top 10 BioPharma Clusters Update

9:40 – Keynote

10:20 – Big Data, Big Science, Big Bio: Today and Tomorrow

11:10 – IP Analysis and Protection

12:00 – Federal Funding C2C

12:50 – FireSide Chat

1:30 – Structured Networking

Agenda Subject To Updates

9:00 – Fireside Chat

9:35 – Infectious Diseases and The Global Pandemic Center

10:25 – Developing and Retaining Talent – Keeping the Best and Brightest in the BHCR

11:15 – Real Estate and Resources in the BHCR

12:05 – Venture Capital Update

12:25 – TBD

1:15 – Closing Remarks

1:30 – Structured Networking

DISTINGUISHED JUDGES

• Rich Bendis (Moderator), President & CEO, BioHealth Innovation, Inc.

Sally Allain, Head, JLABS @ Washington, DC

Andrea Alms, MS, MBA, Fund Manager, BioHealth Capital Fund

Charles Andres, PhD, RAC, Associate, Wilson Sonsini Goodrich & Rosati

Christian Barrow, Executive Director, Life Sciences Banking, JP Morgan

Conley Jones, Senior Associate, Science & Technology, Alexandria Venture Investments

2020 FINALISTS

BrainScope is a medical neurotechnology company improving brain health by providing objective, diagnostic insights that enable better patient care. Using A.I. and machine learning, the FDA-cleared BrainScope One system helps objectively answer key clinician questions for assessment of mild traumatic brain injuries – whether there is a brain bleed or concussion – providing for the first time a full picture of the injury, and doing so in less time, for less cost and without radiation. Learn More by visiting www.BrainScope.com.
Utilizing extensive pharmaceutical experience, CarrTech LLC is a medical device company that has developed and patented a novel medication filtration device. CarrTech is striving to make injectable medication preparation safer and quicker for both patients and healthcare providers. Currently the company is raising funds for a 510 (k) Class II FDA final submission, having completed the presubmission process. Learn more by visiting www.carrtechllc.com.
Chronic daily pain affects more than 50M Americans. Diabetes, medications, chemotherapies, or nerve injury cause neuropathic pain. Poorly treated persistent pain is a silent epidemic that worsens an individual’s quality of life and exacts huge costs, in the US over $560B/Yr in medical expenses, lost productivity, and disability programs. There is a large unmet need for effective non-opioid pain control and Creative Bio-Peptides is developing innovative disease modifying and neuroprotective treatments for chronic pain. Learn more by visiting www.creativebiopeptides.com.
Every day in the US, more than 1000 babies are born prematurely. While each will fight to defeat unimaginable odds, the seemingly simple task of transitioning from feeding tubes to breast or bottle is often the hardest and final hurdle each must overcome prior to discharge. The NTrainer from Innara Health is the only FDA cleared medical device clinically proven to improve feeding outcomes while reducing length of stay for newborns and infants born prematurely. Learn more by visiting www,innarahealth.com.
KaloCyte, Inc. is developing ErythroMer, a dried, bio-inspired artificial red blood cell to treat life-threatening blood loss when stored blood is unavailable, undesirable or in short supply. ErythroMer can be freeze-dried for long-term storage and is a universal option for patients of all blood types. Based in Baltimore, KaloCyte is an Affiliate of UMB and UM BioPark, and is supported by $5.6M in non-dilutive federal grant awards (NIH and DoD), and $1.8M investor funding. Learn more by visiting www.kalocyte.com.

Previous Crab Trap Winners

2019 – Floreo Inc.
Floreo is leveraging the power of Virtual Reality to develop a supplementary method of teaching social and communication skills for individuals with Autism Spectrum Disorder (ASD). Our library of lessons is fun and engaging for the learner, while also providing a supervising adult the opportunity to monitor and track the learner’s progress. Floreo is currently being used by schools, therapy practices, and parents. Floreo’s lessons are science-based; we are currently running several research studies including a study in collaboration with the Center for Autism Research at Children’s Hospital of Philadelphia and National Institutes of Health.
2018 – Galen Robotics
Galen Robotics, is developing, in partnership with JHU, a surgical robot to make minimally invasive surgeries faster, safer and more precise. The company plans a 510k submission next year, is raising Series A financing, and will be relocating the HQ team in CA to join their engineering experts in Baltimore.
2017 – LifeSprout
LifeSprout, developer of revolutionary synthetic soft tissues for aesthetic and reconstructive medicine. Leveraging recent breakthroughs in materials science, they have created a platform that looks and behaves like the body’s own tissues.
2016 –  Sonavex
Sonavex, a commercial stage Johns Hopkins spin-out focused on Empowered Patient Care.  The company’s first technology is a dual-component system comprising an FDA-cleared bioabsorbable implant (EchoMark) and an FDA-cleared custom automated ultrasound (EchoSure) to detect post-operative vascular complications prior to catastrophic surgical failures that represent a $3B annual market and cost hospitals up to $577,000 per instance.

6th Annual BioHealth Capital Region
Crab Trap

DISTINGUISHED JUDGES

• Rich Bendis (Moderator), President & CEO, BioHealth Innovation, Inc.

• Judging Panel Coming Soon

2021 FINALISTS – COMING SOON

 

TBD

 

TBD

 

TBD

 

TBD

 

TBD

Previous Crab Trap Winners

2020 – BrainScope
BrainScope is a developer of a non-invasive medical device intended to objectively assess head-injured patients for both brain bleeds & concussions at point of care. The company’s device is FDA-cleared, portable, EEG-based, assessment tool that empowers physicians to quickly triage patients for brain bleeds, concussion and the need for a CT scan, providing healthcare professionals with objective diagnostic insights that enable better patient care. The company is reportedly in the process of raising $15 million of venture funding on March 25, 2021. The funds will be used to speed up and expand the company’s commercial execution. Previously, The company was approved for a Paycheck Protection Program Loan for $1.07 million from Sandy Spring Bank on April 09, 2020. The application cited 40 jobs to be retained with the financing.
2019 – Floreo Inc.
Floreo is a developer of a learning platform designed to build a new generation of training program for people with autism and other developmental challenges. The company’s platform leverages the power of virtual reality to develop a supplementary method of teaching social and communication skills, enabling individuals with an autism spectrum disorder to build real-world skills. The company was approved for a Paycheck Protection Program Loan in the range of $150,000-350,000 from Wells Fargo Bank, National Association on May 3, 2020. The application cited jobs to be retained with the financing.
2018 – Galen Robotics
Galen Robotics, is a developer of a surgical robot designed to aid surgeons across several disciplines with minimal disturbance to existing workflows. The company’s robot is designed to assist doctors in executing precise movements with certain surgical instruments, while reducing risks from hand shakiness, enabling surgeons to make minimally invasive interventions safer, faster and more precise. The company is reportedly seeking $25 million of Series A venture funding from undisclosed investors as of March 19, 2021. Previously, the company raised $7 million of seed funding from Verte Capital, TEDCO and Maryland Department of Commerce on November 6, 2020.
2017 – LifeSprout
LifeSprout is a Developer of synthetic soft tissue substitutes intended to be used for aesthetic and reconstructive medicine in tissue reproduction. The company’s tissue substitutes focus on regrowth human tissue by transferring tissue from one part of the body to another, enabling doctors to repair patients’ soft tissue damage from trauma, natural aging, surgery, cancer and metabolic disease.
2016 –  Sonavex

Sonavex, a medical device company intended to create novel and automated ultrasound technology. The company has developed a portfolio of novel ultrasound solutions to visualize and quantify critical clinical data for improved outcomes and reduced costs in new surgical applications, empowering clinicians with actionable data to deliver superior patient care and deliver savings to the healthcare system.